Empirical Use of Fluconazole in Critically Ill Patients: Good Study, but What Was the Hold-up?
TO THE EDITOR:
I would like to thank Schuster and colleagues (1) for the excellent article on the empirical use of fluconazole in critically ill patients at high risk for disseminated candidiasis. Their investigation provides valuable data to a broad array of clinicians and addresses an important but understudied area of biomedical research. However, I was troubled …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
